Cite

HARVARD Citation

    Ahrén, B. et al. (2017). Albiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trials. Diabetes research and clinical practice. pp. 230-239. [Online]. 
  
Back to record